Intracranial Arterial Calcification Relates to Long-Term Risk of Recurrent Stroke and Post-stroke Mortality by Wu, X.H. et al.
ORIGINAL RESEARCH
published: 09 October 2020
doi: 10.3389/fneur.2020.559158
Frontiers in Neurology | www.frontiersin.org 1 October 2020 | Volume 11 | Article 559158
Edited by:
Yasushi Takagi,
Tokushima University, Japan
Reviewed by:
Mirjam R. Heldner,
University Hospital Bern, Switzerland
Yasuhisa Kanematsu,
Tokushima University, Japan
*Correspondence:
Xiang Yan Chen
fiona.chen@polyu.edu.hk
Specialty section:
This article was submitted to
Stroke,
a section of the journal
Frontiers in Neurology
Received: 05 May 2020
Accepted: 31 August 2020
Published: 09 October 2020
Citation:
Wu X, Bos D, Ren L, Leung TW,
Chu WC-W, Wong LKS, Abrigo J and
Chen XY (2020) Intracranial Arterial
Calcification Relates to Long-Term
Risk of Recurrent Stroke and
Post-stroke Mortality.
Front. Neurol. 11:559158.
doi: 10.3389/fneur.2020.559158
Intracranial Arterial Calcification
Relates to Long-Term Risk of
Recurrent Stroke and Post-stroke
Mortality
Xiaohong Wu 1, Daniel Bos 2,3, Lijie Ren 1, Thomas Wai-hong Leung 4,
Winnie Chiu-Wing Chu 5, Lawrence Ka Sing Wong 4, Jill Abrigo 5 and Xiang Yan Chen 6*
1Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital,
Shenzhen, China, 2Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands,
3Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands, 4Department of Medicine
and Therapeutics, Chinese University of Hong Kong, Hong Kong, China, 5Department of Imaging and Interventional
Radiology, Chinese University of Hong Kong, Hong Kong, China, 6Department of Health Technology and Informatics, The
Hong Kong Polytechnic University, Hung Hom, Hong Kong
Background: Intracranial arterial calcification (IAC) is highly prevalent in ischemic stroke
patients. However, data on the association of IAC with stroke recurrence and mortality
remains limited. We examined the effect of IAC on the long-term recurrence of stroke
and the risk of post-stroke mortality.
Methods: Using a prospective stroke registry, we recruited 694 patients (mean age 71.6
± 12.4; male sex 50.3%) since December 2004. IAC was visualized using the computed
tomography exam that was made at hospital admission and was quantified with the
Agatston method. All patients were regularly followed up till July 2016. The impacts of
IAC on stroke recurrence and mortality were assessed using Cox-regression models with
adjustments for age, sex, and relevant cardiovascular risk factors.
Results: During a median follow-up period of 8.8 years, 156 patients (22.5%) suffered
a recurrent stroke and 84 died (12.1%). We found that a higher IAC Agatston score
related to a higher risk of stroke recurrence (HR per 1-SD increase in IAC: 1.30; 95%
CI, 1.08–1.56, p = 0.005) and a higher risk of post-stroke mortality (HR per 1-SD
increase, 1.44; 95% CI, 1.06–1.96, p = 0.019). After investigating etiology-specific risks
of stroke-recurrence, we found that a higher IAC Agatston score specifically associated
with small-vessel occlusive stroke.
Conclusions: IAC is a strong risk factor for recurrent stroke and post-stroke
mortality. Among stroke subtypes, IAC relates to higher risk of stroke recurrence among
patients with small-vessel disease, which indicates chronic calcification detected in large
cerebral arteries may have potential effects on the cerebrovascular beds extending to
small vessels.
Keywords: intracranial arterial calcification, stroke recurrence, stroke, atherosclerosis, Agatston score,
post-stroke mortality
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Worldwide, stroke is one of the leading causes of death (1),
and permanent disability (2). Ischemic stroke has a complex
etiology with many contributing causes such as large-artery
atherosclerosis or small-vessel occlusion or cardiac emboli.
Effective prevention could significantly reduce the rates of stroke
recurrence and mortality (3), which may benefit from the
validation of an useful imaging biomarker.
Intracranial arterial calcification (IAC) is frequently observed
on non-contrast computed tomography (CT), which is a routine
imaging investigation for every patient with suspicious stroke.
Our previous clinical studies found a nearly 70% prevalence of
cerebral arteries calcification in Chinese population (4) and a
prevalence of over 80% among stroke patients (5). Inconsistent
with its high prevalence, the effects of IAC on ischemic stroke has
not received much attention. A recent population-based study
in White individuals demonstrated the role of IAC in increasing
the risk of a first stroke (6). Assessing IAC by using quantitative
Agatston score, our recent study found that IAC was closely
associated with cerebral artery stenosis and intracranial micro-
embolism (7–9). However, data on its effects on stroke recurrence
and mortality after stroke remain scarce.
Considering that IAC is a chronic disease within
cerebrovascular system, this prospective study based on a local
stroke registry aimed to investigate the effects of IAC on stroke
recurrence and vascular mortality caused by ischemic stroke.
METHODS
Setting
All consecutive patients that were admitted to the Prince ofWales
Hospital between 1 December 2004 and 31 March 2005 with
ischemic stroke or transient ischemic attack (TIA) were included
in the current study. This study was part of the Prince of Wales
Hospital stroke registry which was described in detail elsewhere
(10). In brief, the Prince of Wales Hospital was the principal
teaching hospital of the Chinese University of Hong Kong
and was a tertiary referral center for the New Territories of
Hong Kong. The acute stroke unit (ASU), to which all patients
with stroke or TIA in this study were admitted, provided all the
stroke beds available in the region (population size: 650,000). This
study provided a recruitment method that was almost identical to
that of a population study.
For the current study, we excluded patients whose incident
stroke was due to venous infarcts, intracranial hemorrhage,
subdural hematoma or subarachnoid hemorrhage. Patients with
other potential causes of IAC, such as hyperparathyroidism
or end-stage renal failure were excluded. Patients who refused
secondary prevention with antiplatelet or anticoagulant therapies
were excluded. Thirty patients were excluded due to obvious
artifacts in the CT images that were not measurable for IAC.
Four patients were excluded due to emigration outside the
geographical area and could not be reached. This left 694 patients
in the current study.
This study was approved by the institutional review board (the
Clinical Research Ethics Committee of the Chinese University of
Hong Kong).
Assessment of Intracranial Arterial
Calcification
At admission, all patients underwent a non-contrast CT
examination of the skull, which was used to assess IAC. All
examinations were performed on a 16-slice multi-detector row
CT system (Light speed 16 plus, General Electric, Milwaukee,
WI, USA) with the following scan parameters: 140 kVp, 170
mAs, 2 s per rotation. Axial images were reconstructed at 0.625
mm intervals.
We evaluated IAC Agatston score using a semi-automatic
procedure which we previously described (7, 8). In brief, CT
source images for each patient were reconstructed to three
dimensional (3D) images by MATLAB (R2015a, the MathWorks
Corporation, MA, USA), and subsequently transferred to 3D
software (Analyze, version 12.0, AnalyzeDirect Inc., KS, USA) for
IAC segmentation with “seeding method” and manual editing.
Then IAC volume was automatically generated by ITK-SNAP
(version 3.4.0, open source software, www.itk-snap.org) (11).
Next, 3D CT images with IAC segments were reconstructed at
3mm intervals by MATLAB. Finally, IAC Agatston score was
automatically generated using a custom-made program with the
Agatston algorithm (12). According to this algorithm, on each 3
mm-thick CT slice, a weighted value was assigned to the highest
artery calcium density within the slice. Weighted value of 1 for
130–199 Hounsfield units (HU), 2 for 200–299 HU, 3 for 300–
399 HU, and 4 for 400 HU or greater. This weighted value was
then multiplied by the area of calcification in the same slice, and
total Agatston score is a summed result of all CT slices.
We defined IAC as hyperdense foci with attenuation number
≥130 HU within any of the following cerebral arteries: right
and left intracranial internal carotid artery (IICA), right and left
anterior cerebral arteries (ACA), right and left middle cerebral
arteries (MCA), right and left posterior cerebral arteries (PCA),
right and left vertebral arteries and basilar artery. The results were
evaluated by an experienced neurologist blinded to all the clinical
data of the study population.
Follow-Up of Stroke Recurrence and
Post-stroke Mortality
Patients admitted to the ASU were followed up using Clinical
Management System (CMS), a territory-wide and networked
clinical records system which was utilized by the Hospital
Authority throughout all government hospitals in Hong Kong.
All study patients who were discharged from the hospital were
followed up regularly till June 1, 2016 for ischemic stroke
recurrence and post-stroke mortality. Deaths classified as due
to stroke causes were death from stroke that occurred within 7
days after the current stroke or another stroke during follow-
up period. A search of the patient’s serial CMS records was
performed to identify any development of recurrent ischemic
stroke or related mortality across the Hong Kong government
hospital system.
Clinical Data and Stroke Subtypes
Clinical data of demographic characteristics, stroke risk factors,
and stroke etiology of the patients were retrieved from the
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data-collection sheets of stroke registry collected on entry
and obtained by record linkage to the CMS. Demographic
characteristics included age and sex. Stroke risk factors for each
patient were documented regarding the following: hypertension,
diabetes mellitus, hyperlipidemia, atrial fibrillation, ischemic
heart disease, two or more ischemic stroke history and ever
smoking. The stroke etiology (TOAST, Trial of ORG 10172 in
Acute Stroke Treatment criteria) (13) was classified as large-
artery atherosclerosis, small-vessel occlusion, cardioembolism,
other determined etiology, undetermined etiology, and two or
more causes identified.
Statistical Analysis
Given the skewed distribution of the IAC Agatston score we
applied a natural log-transformation after 1 was added to the
non-transformed values to deal with zero calcium scores [Ln
(IAC + 1.0)]. Cox proportional hazards regression models
were used to investigate the association of the presence of
IAC and IAC Agatston scores with stroke recurrence and
post-stroke mortality. In the first model we show the crude,
unadjusted effect estimates. In the second model we adjusted
all analyses for age, sex, hypertension, diabetes mellitus, atrial
fibrillation, hyperlipidaemia, ischemic heart diseases, two or
more ischemic stroke history and ever smoking. Next, we
analyzed the association of IAC Agatston score with stroke
subtypes (large-artery atherosclerosis, small-vessel occlusion,
cardioembolism). Finally, we used Kaplan-Meier curves and log-
rank tests for estimation of stroke recurrence and post-stroke
mortality for patient groups with higher (>=median score) or
lower (<median score) IAC Agatston scores. A significance level
of 0.05 was used for all analyses. The SPSS software SPSS (version
16.0, IBM SPSS Statistics, Chicago, U.S.A.) was employed for
this study.
RESULTS
The baseline characteristics of the study population are provided
in Table 1. The mean age of the patients was 72 years (age
range: 28–101 years) and 49.7%were females. Themost prevalent
stroke-etiology was large-artery atherosclerosis (40.0%, 233/582).
Small-vessel occlusion was found in 167 patients (28.7%),
cardioembolic stroke in 124 patients (21.3%), other determined
etiology in 10 patients (1.7%), and cryptogenic causes in 5
patients (0.9%). Two ormore causes were identified in 43 patients
(7.4%). IAC was found in 643 patients (92.7%) (Table 2).
Stroke Recurrence and Post-stroke
Mortality
During a median follow-up period of 8.8 years (interquartile
range 3.2–11.1 years), 156 patients (22.5%) suffered a recurrent
stroke and 84 (12.1%) died within 7 days after the initial stroke.
Table 3 shows the associations between IAC characteristics
and risks of stroke recurrence.We found that IACAgatston score
was related to a higher risk of recurrent stroke independent of
cardiovascular risk factors (HR per 1-SD increase in IAC, 1.30;
95% CI, 1.08–1.56, p= 0.005) (Table 3, model 2).
TABLE 1 | Baseline characteristics.
Characteristic Total (n = 694)
Vascular risk factors
Age (years) (mean/SD) 71.6 (12.4)
Sex (male), % 349 (50.3)
Hypertension, % 503 (72.5)
Diabetes mellitus, % 232 (33.4)
Hyperlipidaemia, % 360 (51.9)
Atrial fibrillation, % 148 (21.3)
Ischemic heart diseases, % 98 (14.1)
Two or more ischemic stroke history, % 170 (24.5)
Ever smoking, % 195 (28.1)
TIA 112 (16.1%)
Ischemic stroke 582 (83.9%)
TOAST classification
Large-artery atherosclerosis 233 (40.0%)
Small-vessel occlusion 167 (28.7%)
Cardioembolism 124 (21.3%)
Other determined etiology 10 (1.7%)
Undetermined etiology 5 (0.9%)
Two or more causes identified 43 (7.4%)
IAC characteristics
Presence of IAC, % 643 (92.7)
IAC volume (mm3 ) (median/IQR) 169.3 (40.9–431.7)
IAC Agatston score (median/IQR) 64.8 (14.8–180.7)
IAC, intracranial arterial calcification; SD, standard deviation; IQR, interquartile range.
TABLE 2 | Prevalence of intracranial artery calcification in 694 patients.
IICA ACA MCA PCA Basilar
artery
Vertebral
artery
Any
intracranial
arteries
641 (92.4%) 1 (0.1%) 25 (3.6%) 0 (0%) 20 (2.9%) 272
(39.2%)
643 (92.7%)
For the associations between IAC characteristics and risks of
post-stroke mortality, we found that IAC Agatston score was
independently related to a higher risk of post-stroke mortality
(HR per 1-SD increase in IAC, 1.44; 95% CI, 1.06–1.96) (Table 3,
model 2).
Stroke Recurrence in Patients With Stroke
of Different Etiological Subtypes or TIA
We found 133 (22.9%) recurrence stroke in 582 stroke patients,
and 23 (20.5%) in 112 TIA patients (Table 4). Among the 133
recurrence cases, 54 (23.2%) were found in patient with index
large-artery atherosclerotic stroke, 34 (20.4%) in patient with
index small-vessel occlusive stroke, and 27 (21.8%) with index
cardioembolic stroke.
For patients with index small-vessel occlusive stroke, IAC
Agatston score was found to be associated with a higher risk of
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stroke recurrence (HR per 1-SD increase in IAC, 1.67; 95% CI,
1.06–2.64, p= 0.027) independent of age and hypertension.
The Kaplan–Meier Risk of Stroke
Recurrence and Post-stroke Mortality
The Kaplan-Meier curves and log-rank tests showed significantly
higher rates of stroke recurrence (P = 0.001) and lower rates
of post-stroke survival (P < 0.001) in patients with higher IAC
Agatston score (Figure 1). In this group, the risk of developing
recurrent stroke was 9.2% at 1 year, 21.0% at 5 years, and 25.6%
at 10 years. While for patients with lower IAC Agatston score, the
risk was much lower, with 6.9% at 1 year, 13.5% at 5 years, and
18.7% at 10 years.
DISCUSSION
In this cohort study, we found IAC was associated with the risk of
recurrent stroke and post-stroke mortality during over 10 years
of follow-up. In addition, index small-vessel occlusive stroke
patients who had higher IAC score were particularly vulnerable
for another stroke.
TABLE 3 | Association of IAC with stroke recurrence and mortality after stroke.
Ischemic stroke (n = 156) Stroke death (n = 84)
IAC characteristic HR (95% CI) P-value HR (95% CI) P-value
Presence of IAC
Model 1 1.80 (0.88, 3.66) 0.107 7.49 (1.04, 53.83) 0.045
Model 2 1.23 (0.57, 2.66) 0.599 3.17 (0.42, 23.79) 0.262
IAC Agatston score, per
1-SD increment
Model 1 1.40 (1.17, 1.67) 0.000 1.756 (1.34, 2.30) 0.000
Model 2 1.30 (1.08, 1.56) 0.005 1.441 (1.06, 1.96) 0.019
Model 1: the crude, unadjusted effect estimates. Model 2: adjusted for age, sex,
hypertension, diabetes mellitus, atrial fibrillation, hyperlipidaemia, ischemic heart diseases,
two or more ischemic stroke history and ever smoking.
IAC, intracranial arterial calcification; HR, hazard ratio; CI, confident interval.
In the term of IAC impact on ischemic event risk, Mak et al.
(5) in a prospective study involving 60 Chinese stroke patients
failed to verify the association between IAC and stroke recurrence
(14). Different from the study involving Asians, a French research
group in 2011 followed up 302 stroke patients over 1 year
and demonstrated that a visual IAC score might constitute a
risk factor of total future major clinical events (15). Similarly,
Ovesen et al. (16) found that the severity of IAC (graded as
the number of calcified cerebral arteries) predicted an increased
risk of total recurrent ischemic events in a Danish population.
However, in these early studies the direct association between
IAC and ischemic stroke was not shown. One explanation might
be that, IAC was qualitatively assessed with visual scales in
these studies, but not quantified, which failed to fully reflect
the IAC characteristics. Recently with a quantified software, the
Rotterdam Study–a large population-based cohort study in a
general community—established the IICA calcification volume
to be a major risk factor for a first stroke in a White population
(6). Symptomatic intracranial atherosclerotic stenoses patients
have recently been found to experience more cerebrovascular
events, event under best prevention management, compared
to asymptomatic ones with similar vascular risk factors (17).
In this study, we concerned about the stroke population who
had a higher incidence of IAC. With a quantitative-evaluated
IAC Agatston score reflecting both calcium volume and density
information, our study demonstrated the association between
IAC and recurrent ischemic stroke. The important values of IAC
Agatston score may help high risk patient’s stratification and
management optimization in clinical practice.
In the field about prognostic value of IAC on specific stroke
subtypes, little was known. A cross-sectional subgroup analysis
based on the Rotterdam Study showed that compared to lacunar
ischemic strokes (small vessel disease), non-lacunar strokes is
associated with a larger aortic arch calcification volume (18),
which confirmed extent arterial calcifications differ on different
etiologies. Different to this study, we longitudinally followed
up the stroke patients. Our study found that among different
stroke etiological subtypes, IAC was independently related to
stroke recurrence in patients with index small-vessel occlusive
stroke. This finding implicated that IAC play various roles
TABLE 4 | Cox proportional hazard model for predictive value of IAC Agatston score on patient groups with index TIA or different major stroke subtypes.
Category NO. Re-stroke during
follow-up period
Crude HR
(per 1-SD
increase in IAC)
P-value Adjusted HR
(per 1-SD
increase in IAC)
P-value
All patients 694 156 (22.5%) 1.40 (1.17, 1.67) 0.000 1.36 (1.10, 1.67) 0.004
TIA 112 23 (20.5%) 1.27 (0.85, 1.89) 0.237 1.20 (0.76, 1.91) 0.435
Ischemic stroke 582 133 (22.9%) 1.41 (1.16, 1.72) 0.000 1.39 (1.09, 1.76) 0.007
Stroke subtype 582
Large-artery atherosclerosis 233 54 (23.2%) 1.30 (0.94, 1.78) 0.108 1.20 (0.83, 1.72) 0.328
Small-vessel occlusion 167 34 (20.4%) 1.48 (1.02, 2.16) 0.040 1.67 (1.06, 2.64) 0.027
Cardioembolism 124 27 (21.8%) 1.57 (0.92, 2.70) 0.099 1.06 (0.58, 1.95) 0.842
HR, Hazard ratio.
Adjusted for age and hypertension.
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FIGURE 1 | Kaplan-Meier survival plots of stroke recurrence and stroke death. Patients with higher IAC Agatston score had significantly poorer outcomes (recurrent
stroke or stroke death) than those with lower score. (A) Kaplan-Meier survival plot for patients free of recurrent stroke. (B) Kaplan-Meier survival plot for stroke survival.
on different causes of stroke and small-vessel occlusive stroke
patients with more severe IAC may be particularly vulnerable for
another stroke.
For arterial calcification detected on CT, there are now three
recognized patterns: intimal calcification which is indicative
of a proxy for intracranial atherosclerosis documented in our
previous histological study, medial calcification described by
Mönckeberg, and internal elastic lamina calcification which is
associated with stiffening of the arterial wall and increased
pulse pressure (19–23). This study quantitatively evaluated IAC
on CT, which include all there above patterns. Although the
latter two patterns are currently considered non-atherosclerotic
calcification, they could contribute to increased mechanical
stress on atherosclerotic plaques, and effect the plaque sequelae
potentially. This may be one explanation for the association
between quantitatively-evaluated IAC and subsequent events.
Besides, association between extent of arterial calcification and
stroke prognosis in different ethnicities would also be an
interesting point worthy of future attention.
This study presents some strengths. First, consecutive patients
are studied on a prospective registry. Second, we use quantitative
methods to evaluate arterial calcification, which contain both
calcium volume and density information, and reflect the severity
of IAC more objectively and authentically than visual scales.
Third, we evaluate IAC on non-contrast head CT, which is non-
invasive and easily acquired in general hospitals. Finally, this is a
very long-term study and the majority of patients are successfully
followed up. On the other hand, some limitations exist in this
study, including overestimation of extent of vascular calcification
in CT imaging, the absence of stroke severity on admission, the
absence of treatment for stroke, monocentric study, and the small
sample size especially among different stroke subtypes. Yet, as a
preliminary study it can provide considerable value for reference
in future clinical research.
CONCLUSION
The quantitatively-evaluated IAC relates to long-term stroke
recurrence and vascular mortality. Among stroke subtypes, IAC
is associated with recurrent stroke among small-vessel occlusive
patients, which indicates choric calcification detected in large
cerebral arteries may have potential effects on the cerebrovascular
beds extending to small vessels.
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